Find clinical trials for Melanoma in Jacksonville, FL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Melanoma trials near Jacksonville, FL, USA:
This is a Phase 3, randomized, multi-center, open-label study of neoadjuvant darovasertib in subjects with primary non-metastatic uveal melanoma...
Phase 3
Jacksonville, Florida, United States and 74 other locations
therapy per local standard of care \[SoC\], best supportive care \[BSC\] on protocol survivor follow up) in patients with advanced non-ocular melanoma...
Phase 3
Jacksonville, Florida, United States and 71 other locations
and overall survival (OS) for patients with NRAS-mutant (NRASm) melanoma who are randomized to receive the combination of naporafenib + tram...
Phase 3
Jacksonville, Florida, United States and 58 other locations
The study is focused on patients with a type of skin cancer known as melanoma. The aim of the study is to see how safe and effective the com...
Phase 3
Jacksonville, Florida, United States and 100 other locations
not worse than nivolumab + relatlimab FDC intravenous (IV) administration in participants with previously untreated metastatic or unresectable melanoma...
Phase 3
Jacksonville, Florida, United States and 152 other locations
This is a single arm phase II clinical trial of Ipilimumab and Nivolumab in patients with resected mucosal melanoma. Ipilimumab (1 mg/kg) an...
Phase 2
Jacksonville, Florida, United States and 6 other locations
study is to determine whether relatlimab in combination with nivolumab is more effective than nivolumab monotherapy in treating unresectable melanoma...
Phase 2, Phase 3
Jacksonville, Florida, United States and 126 other locations
combined with nivolumab in patients with unresectable or metastatic melanoma. A separate open-label cohort of adults with new, progressive b...
Phase 3
Jacksonville, Florida, United States and 138 other locations
(IMC-F106C) plus nivolumab compared to standard nivolumab regimens in HLA-A\*02:01-positive participants with previously untreated advanced melanoma...
Phase 3
Jacksonville, Florida, United States and 174 other locations
placebo in participants with surgically resected high-risk Stage II melanoma. Participants in Part 1 will receive either pembrolizumab or pl...
Phase 3
Jacksonville, Florida, United States and 158 other locations
Clinical trials
Research sites
Resources
Legal